Le Lézard
Classified in: Health, Covid-19 virus
Subject: SBS

Physician Wellness Champion Retreat Builds the Wellness Leaders Required for the Post-Pandemic Healthcare Delivery System


SEATTLE, June 30, 2020 /PRNewswire/ -- COVID-19 has changed healthcare and the experience of being a physician forever. The old normal is gone. Dike Drummond MD, CEO of TheHappyMD.com has this question for healthcare leaders: "Do you believe the health and wellbeing of the physicians and staff will be more important  - or less important in the post-pandemic world?"

Where can hospitals and medical groups find the Wellness Leaders they need to prevent today's epidemic rates of Physician Burnout. Where can they learn the skills to hard wire Physician Wellness into the New Normal of healthcare delivery in the wake of COVID-19?

TheHappyMD.com, the original online source for physician burnout coaching, built the "Quadruple Aim Physician Leadership Retreat" based on experience training over 40,000 doctors to recognize and prevent burnout. The retreat is a complete Physician Wellness Champion "Boot Camp" designed to prevent physician burnout system wide. Launched in 2017, six previous retreat classes have graduated 181 Wellness Champions for organizations on four continents.

Registration is Now Open
The Next Retreat is September 24 ? 27, 2020 at the Edgewater Hotel in Seattle, Washington
Download the Complete Retreat Overview at This Link
[ https://tinyurl.com/QAPLRFall2020Overview ]
Tuition Discounts Available for FQHC, Critical Access Hospitals, MedEd and Groups of 2 or more

Over 3 ½ days, this intimate group of only 36 physician leaders will learn and practice:

- How to recognize, prevent and treat burnout in yourself, your direct reports and teams
- Proven tools to get home sooner, lower stress and build life balance
- Communication skills to transform physician resistance and build team trust and engagement
- Tools to run much better meetings, delegate effectively, give quality feedback to direct reports
- Techniques to navigate bureaucracy and manage your boss
- The four-part Quadruple Aim Blueprint Strategy for proactive, organization-wide burnout prevention

The retreat also offers:

- 13 hours of Continuing Medical Education
- A comprehensive 12-week follow up support system to ensure immediate leadership effectiveness on the participant's return home.  Graduates receive weekly coaching calls, a weekly newsletter and exclusive access to a private online support forum for a full three months after the retreat.

About Dike Drummond MD and TheHappyMD.com

Since 2010, TheHappyMD.com [www.thehappymd.com] is the original online source of coaching, training and consulting to prevent physician burnout. CEO, Dike Drummond MD [www.thehappymd.com/about-the-happy-md] is a Family Physician and executive coach with over 2500 hours of one-on-one physician coaching experience. Dr. Drummond has trained over 40,000 physicians to recognize and prevent burnout on behalf of 175 major healthcare organizations on four continents to date.

Press Contact:
Wendy Kunz
Chief Operations Officer
[email protected]
206-430-1905

 

SOURCE TheHappyMD.com


These press releases may also interest you

at 07:45
Sensi.AI, a leader in AI-native, data, and analytics in senior care, today announced the appointment of in-home care leader Bob Roth to its Advisory Board. This partnership is an exciting validation of Sensi.AI's promise to enhance proactive,...

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...



News published on and distributed by: